Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Stoke Therapeutics (STOK) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to 0.55.

  • Stoke Therapeutics' Asset Utilization Ratio rose 89120.5% to 0.55 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.55, marking a year-over-year increase of 89120.5%. This contributed to the annual value of 0.15 for FY2024, which is 30344.46% up from last year.
  • According to the latest figures from Q3 2025, Stoke Therapeutics' Asset Utilization Ratio is 0.55, which was up 89120.5% from 0.51 recorded in Q2 2025.
  • Stoke Therapeutics' 5-year Asset Utilization Ratio high stood at 0.56 for Q1 2025, and its period low was 0.05 during Q4 2022.
  • Moreover, its 4-year median value for Asset Utilization Ratio was 0.06 (2024), whereas its average is 0.18.
  • As far as peak fluctuations go, Stoke Therapeutics' Asset Utilization Ratio tumbled by 260.67% in 2024, and later soared by 89120.5% in 2025.
  • Over the past 4 years, Stoke Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.05 in 2022, then rose by 26.28% to 0.06 in 2023, then skyrocketed by 120.48% to 0.13 in 2024, then surged by 326.65% to 0.55 in 2025.
  • Its Asset Utilization Ratio was 0.55 in Q3 2025, compared to 0.51 in Q2 2025 and 0.56 in Q1 2025.